<DOC>
	<DOCNO>NCT02850939</DOCNO>
	<brief_summary>Adjuvant endocrine hormonal therapy ( EHT ) highly effective appropriate nearly breast cancer patient hormone receptor-positive tumor , represent 75 % breast cancer diagnose . Long-term use EHT reduce cancer recurrence rate cut risk death nearly half second decade diagnosis , research show . Despite proven benefit , 33 % woman prescribe EHT take medication prescribe ( less 80 % take daily dosage ) thus high risk recurrence death . This educational randomized control study develop pilot-test bilingual , culturally tailor , personalize , interactive mobile application ( app ) combination patient navigation promote improve adherence endocrine hormonal therapy ( EHT ) among breast cancer patient .</brief_summary>
	<brief_title>Improving Adherence EHT Among Breast Cancer Patients</brief_title>
	<detailed_description>The propose two-year study involve 2-group randomized control trial 3-time assessment ( baseline , 3 6 month ) enroll 120 breast cancer patient prescribe EHT attend breast clinic Cancer Therapy Research Center ( CTRC ) , National Cancer Institute-designated cancer center University Texas Health Science Center San Antonio . The intervention group receive two component : 1 ) bilingual , culturally tailor , personalize , interactive mobile app ; 2 ) support patient navigator . The control group receive usual care information provide CTRC 's breast clinic pharmacy patient undergoing oral EHT . The intervention component base Social Cognitive Theory elements Motivational Interviewing . The propose study aim : 1 . Develop bilingual , culturally tailor , personalize , interactive mobile application ( app ) promote improve EHT adherence among breast cancer patient diagnose hormone receptor positive breast cancer . The app empower patient ' self-monitoring management , well facilitate patient education , early identification report side effect , delivery self-care advice , timely feedback direct interaction patient oncology team necessary . 2 . Conduct 2-group randomize control study ass feasibility effectiveness bilingual , culturally tailor , personalize , interactive app + patient navigation ( PN ) promote EHT adherence compare usual care among patient diagnose hormone receptor-positive breast cancer prescribe EHT .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<criteria>English Spanish speaking adult patient , 18 year age old : ) diagnose hormone receptorpositive breast cancer prescribe endocrine hormonal treatment ( EHT ) ; b ) cell phone , able send receive text message access internet ; c ) able provide inform consent participate study . Patients : ( ) unable provide consent due mental , emotional , physical handicap , keep understanding consent information ; ( b ) smart phone ; ( c ) unable respond text message question unable download study app ; ) unable see app study material videos ( i.e. , blind , deaf )</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>Breast cancer</keyword>
	<keyword>Endocrine hormonal therapy</keyword>
	<keyword>mHealth</keyword>
</DOC>